派博傳思國(guó)際中心

標(biāo)題: Titlebook: Nano Drug Delivery for Cancer Therapy; Principles and Pract Firdos Alam Khan Book 2023 The Editor(s) (if applicable) and The Author(s), und [打印本頁(yè)]

作者: 法庭    時(shí)間: 2025-3-21 18:53
書目名稱Nano Drug Delivery for Cancer Therapy影響因子(影響力)




書目名稱Nano Drug Delivery for Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Nano Drug Delivery for Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy被引頻次




書目名稱Nano Drug Delivery for Cancer Therapy被引頻次學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy年度引用




書目名稱Nano Drug Delivery for Cancer Therapy年度引用學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy讀者反饋




書目名稱Nano Drug Delivery for Cancer Therapy讀者反饋學(xué)科排名





作者: Fracture    時(shí)間: 2025-3-21 21:51
Book 2023 and lung cancer. It reviews the significance of nano drug delivery in cancer therapy, the application of nanoparticles in overcoming drug resistance, targeted therapy, and immunotherapy. The book also covers topics related to the synthesis of different types, shapes, and sizes of nanocarriers using
作者: debase    時(shí)間: 2025-3-22 04:07

作者: conference    時(shí)間: 2025-3-22 05:59
Firdos Alam KhanDiscusses applications of nano drug delivery.Explains the synthesis functionalized and conjugation nanocarriers.Elaborates on advantages and limitations of nanocarriers
作者: Constitution    時(shí)間: 2025-3-22 11:39

作者: nonradioactive    時(shí)間: 2025-3-22 14:06

作者: Colonoscopy    時(shí)間: 2025-3-22 17:32

作者: 種植,培養(yǎng)    時(shí)間: 2025-3-22 23:19
Synthesis of Different Types, Shapes, and Sizes of Nanocarriers Using Synthetic and Biological Apprinal product’s characteristics such as size and morphology, selection of the proper method is critical. In general, the nanomaterial synthesis methods can be classified into two main categories: top-down and bottom-up. In the top-down methods, bulk materials are converted into nanomaterials using sp
作者: Adj異類的    時(shí)間: 2025-3-23 02:00
Synthesis of Nanocarriers Loaded with Anti-Cancer Drugs by Using Functionalization or Conjugations,ea, designable pore structures, and robust mechanical/chemical stability with adjustable optical and electrical properties. Inorganic nanoparticles are interesting as nanocarriers for drug delivery due to the chemical, mechanical strength, microbial resistance, and biocompatibility. The presence of
作者: preservative    時(shí)間: 2025-3-23 08:33
Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment, well as therapeutic molecules for its treatment. However, innumerable chemotherapeutics that are experimentally evaluated are unable to reach bench to bedside due to many drawbacks. These include poor bioavailability, lower bioretention, and non-specific effects along with systemic toxicity. Additi
作者: 胡言亂語(yǔ)    時(shí)間: 2025-3-23 10:20

作者: 神經(jīng)    時(shí)間: 2025-3-23 14:34
Testing of Nanocarriers Loaded with Chemotherapeutic Agents: Cancer Patients and Clinical Trials,ns. Some of the best-studied nanomaterials are metallic nanomaterials, polymeric nanomaterials or other organic and inorganic nanomaterials which showed promising applications in cancer diagnosis and cancer therapy. As per the report which was published in the 2016, there are 25 different types of n
作者: 發(fā)展    時(shí)間: 2025-3-23 21:09

作者: 泥沼    時(shí)間: 2025-3-24 01:04

作者: Abduct    時(shí)間: 2025-3-24 05:45
Health and Environmental Hazards Associated with the Synthesis of Nanomaterials-Respiratory Diseasemall size together with astonishing physicochemical properties, which makes them most suitable for therapeutic applications. Different types of nanomaterials, such as metallic, carbon-based, fluorescent, and polymer-based, have been used in tissue engineering, drug delivery, and other therapeutic ap
作者: Restenosis    時(shí)間: 2025-3-24 07:03

作者: notification    時(shí)間: 2025-3-24 14:20
Significance of Nano-drug Delivery in Cancer Therapy, Application of Nanoparticles in Overcoming Dried for cancer treatment. This chapter discusses numerous types of NPs, targeting mechanisms, immunotherapy, and the importance of nanotechnology in cancer treatment. Further, we also summarize the future perspectives. Overall, further research in this area will lead to new innovative methodologies
作者: conservative    時(shí)間: 2025-3-24 15:04
Synthesis of Different Types, Shapes, and Sizes of Nanocarriers Using Synthetic and Biological Apprypes of nanomaterials can be used as carriers for cancer therapy, including zero-dimensional (0D), one-dimensional (1D), two-dimensional (2D), and three-dimensional (3D) nanomaterials. This chapter investigates the most important synthesis methods for the abovementioned nanomaterials and evaluates t
作者: 鉤針織物    時(shí)間: 2025-3-24 19:28

作者: Ledger    時(shí)間: 2025-3-25 01:30

作者: invulnerable    時(shí)間: 2025-3-25 03:28
Testing of Nanocarriers Loaded with Chemotherapeutic Agents in the Animal Models of Cancers: Preclisted in animal models for their preclinical testing. This chapter focused on the use of various animal models been used so?far for the testing of these nanocarriers to assess their efficacy in preclinical setup. Animal models are classified according to the method by which cancer is induced in the a
作者: Texture    時(shí)間: 2025-3-25 11:15

作者: Nonconformist    時(shí)間: 2025-3-25 14:01

作者: Inflammation    時(shí)間: 2025-3-25 19:46

作者: 同時(shí)發(fā)生    時(shí)間: 2025-3-25 23:49

作者: 焦慮    時(shí)間: 2025-3-26 02:29
Future Trends and Innovation in Nano Drug Delivery for Cancer Therapy, Application of siRNA (Nanopambinations of ultrasounds and nano-systems for cancer treatment has been reviewed, the current chapter introduces the biogenesis and uptake of exosomes and compares different approaches for isolation and drug loading, focusing on the application and current challenges of exosomes as drug delivery ve
作者: 可能性    時(shí)間: 2025-3-26 04:56

作者: 思考    時(shí)間: 2025-3-26 11:31

作者: ciliary-body    時(shí)間: 2025-3-26 12:39
Priyanca Ahlawat,Rohit Kumar,Akhilesh Kumar,Piyush Kumar Gupta
作者: mediocrity    時(shí)間: 2025-3-26 19:41

作者: Suppository    時(shí)間: 2025-3-26 21:04
Kanwal Abbasi,Kauser Siddiqui,Saeeda Bano,Samina Iqbal,Shagufta A. Shaikh
作者: GRACE    時(shí)間: 2025-3-27 04:57
7樓
作者: Agnosia    時(shí)間: 2025-3-27 05:28
8樓
作者: 搜集    時(shí)間: 2025-3-27 11:49
8樓
作者: 序曲    時(shí)間: 2025-3-27 13:39
8樓
作者: brother    時(shí)間: 2025-3-27 18:21
8樓
作者: –DOX    時(shí)間: 2025-3-27 22:01
9樓
作者: Chronological    時(shí)間: 2025-3-28 05:08
9樓
作者: Wordlist    時(shí)間: 2025-3-28 08:05
9樓
作者: 觀察    時(shí)間: 2025-3-28 12:29
9樓
作者: 解脫    時(shí)間: 2025-3-28 17:24
10樓
作者: giggle    時(shí)間: 2025-3-28 20:22
10樓
作者: 觀點(diǎn)    時(shí)間: 2025-3-29 02:37
10樓
作者: enlist    時(shí)間: 2025-3-29 06:30
10樓




歡迎光臨 派博傳思國(guó)際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
新郑市| 青岛市| 余庆县| 永川市| 大荔县| 甘肃省| 满洲里市| 米脂县| 阳信县| 南投市| 安吉县| 西充县| 宁津县| 昌江| 梅河口市| 靖州| 济宁市| 楚雄市| 太原市| 横峰县| 莱芜市| 永川市| 色达县| 湘阴县| 平利县| 奇台县| 调兵山市| 夏邑县| 达州市| 沅陵县| 盐边县| 永清县| 朝阳县| 分宜县| 霞浦县| 杂多县| 澎湖县| 武定县| 钟山县| 湘乡市| 邹平县|